|
|
|
|
| LEADER |
01303nam a2200241 u 4500 |
| 001 |
EB002220392 |
| 003 |
EBX01000000000000001357353 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
240703 r ||| eng |
| 100 |
1 |
|
|a Yeung, Shirley S. T.
|
| 245 |
0 |
0 |
|a Silver diamine fluoride for the prevention and arresting of dental caries or hypersensitivity
|h Elektronische Ressource
|b a review of clinical effectiveness, cost-effectiveness and guidelines
|c Shirley S. T. Yeung, Charlene Argáez
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2017, July 10, 2017
|
| 300 |
|
|
|a 1 PDF file (27 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 700 |
1 |
|
|a Argáez, Charlene
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK493244
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of this report is to review the clinical and cost-effectiveness of silver diamine fluoride for the prevention and arrest of dental caries or hypersensitivity, as well as the guidelines for its use
|